Compare Cassava Sciences Inc (FLNA) vs Standard Lithium Ltd (SLI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Standard Lithium Ltd — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while Standard Lithium Ltd trades at $2.41 (market cap $604.50M). The key difference: Standard Lithium Ltd is far larger — about 12.7× Cassava Sciences Inc's market cap, and Standard Lithium Ltd is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | SLI | |
|---|---|---|
Market Cap | $47.75M | $604.50M |
Sector | Health | Basic Materials |
52-Week High | $4.64 | $5.65 |
52-Week Low | $0.87 | $1.93 |
Enterprise Value | -$34.93M | $467.42M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Standard Lithium Ltd
Standard Lithium Ltd. is a company focused on the development of lithium projects in North America, with a primary focus on extracting lithium from brine resources. Their flagship projects aim to utilize proprietary, advanced direct lithium extraction (DLE) technologies to produce high-purity lithium compounds in an environmentally responsible manner. The company seeks to become a key domestic supplier to the growing electric vehicle and battery storage markets.
Read more on SLI →
